News | December 21, 2021
Stelis commissions vaccine facility in Bengaluru
The company has started manufacturing the Sputnik Light vaccine
The company has started manufacturing the Sputnik Light vaccine
Applied Biosystems CoviPath COVID-19 RT-PCR Kit is approved for in vitro diagnostic use by ICMR and DCGI.
The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
The precision health platform integrates genetics, biomarkers, diet, and lifestyle data to deliver personalised gut health interventions and therapy support
More than 3,500 participants will join the nationwide AI-focused hackathon hosted as Indian Institute of Science
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
Approval for generic Semaglutide Injection strengthens CDMO partnership, enabling scalable supply from OneSource’s US FDA-approved Bengaluru facility
The initiative is designed to benefit patients as well as healthcare providers by streamlining access to consultations, diagnostics, and essential care services
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
Subscribe To Our Newsletter & Stay Updated
